HOWELL SCOTT LAVERNE

PrivateCIK: 2128384
Location

WASHINGTON, DC

HOWELL SCOTT LAVERNE enters VANDA PHARMACEUTICALS INC. with 342.15K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Indirect Derivatives
InsiderHOWELL SCOTT LAVERNECIK 2128384
Officer· VP and Chief People Officer
Since Apr 2026
342.15K
Baseline shares
97% direct
332.54K
Direct ownership
5 positions
192.30K
Derivative underlying
4 instruments
6
Security positions
9.62K indirect
Non-Derivative Holdings6

Common Stock

Direct
Shares owned100K

Common Stock

Indirect
Shares owned9.62K

Common Stock

Direct
Shares owned50K

Common Stock

Direct
Shares owned99.36K

Common Stock

Direct
Shares owned8.18K

Common Stock

Direct
Shares owned75K
Total
332.54K direct·9.62K indirect342.15K
Derivative Holdings4

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

28.60K

Shares owned

N/A

Exercise price

20.28

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

77.50K

Shares owned

N/A

Exercise price

7.05

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

25K

Shares owned

N/A

Exercise price

11.32

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

61.20K

Shares owned

N/A

Exercise price

11.36

Expiration

Exercise window

Total

Underlying

192.30K

Owned

0.00

HOWELL SCOTT LAVERNE — Initial Ownership Disclosure (Form 3) Filed Apr 13, 2026 | Finecho